Lifestyle FDA Approves Topical Foam for Plaque Psoriasis of the Scalp and Body May 27, 2025 Zoryve roflumilast
Lifestyle FDA Approves Topical Foam for Plaque Psoriasis of the Scalp and Body May 27, 2025 TUESDAY, May 27, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Zoryve (roflumilast) topical foam 0.3 percent for…